By Tom Zanki ( March 27, 2017, 7:31 PM EDT) -- Akcea Therapeutics Inc., a late-stage biotech being spun out of Ionis Pharmaceuticals Inc., on Monday filed a $100 million initial public offering under guidance from Cooley LLP, seeking to raise money to support its pipeline of therapies treating lipid disorders....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.